


| Key | % Net Assets |
|---|---|
| 7.7% | |
| 6.2% | |
| 5.7% | |
| 5.6% | |
| 74.8% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 7.7% |
| BG | 6.2% |
| Royal Dutch Shell ''A'' (UK list) | 5.7% |
| BP | 5.6% |
| BT | 5.0% |
| AstraZeneca | 4.9% |
| Vodafone | 4.8% |
| Imperial Tobacco | 4.5% |
| National Grid | 3.9% |
| Rolls-Royce | 3.1% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 204.23p |
| Currency | GBP |
| Change | -0.11p |
| % | -0.05% |
| YTD change | 25.05p |
| YTD % | 13.98% |
| Fund Inception | 12/06/1987 |
|---|---|
| Fund Manager | Ed Burke |
| TER | 1.19 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £20 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.16% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research